Vanguard Total Stock Market ETF (VTI)
286.72
-0.05 (-0.02%)
NYSE · Last Trade: May 22nd, 10:47 PM EDT
Detailed Quote
Previous Close | 286.77 |
---|---|
Open | 286.38 |
Day's Range | 285.88 - 288.53 |
52 Week Range | 236.42 - 303.39 |
Volume | 2,738,677 |
Market Cap | 4.67B |
Dividend & Yield | 3.940 (1.37%) |
1 Month Average Volume | 3,289,611 |
Chart
News & Press Releases
The company said it was becoming a one-stop shop for AI agents and AI-enabled human experts to fuel the success of consumers and small and mid-market businesses.
Via Stocktwits · May 22, 2025
Doxey said that Southwest expects unit revenue to fall more in the second quarter compared to the decline in the first quarter.
Via Stocktwits · May 22, 2025
The proceeds from the preferred stock offering will be used for operations, liquidity, and Bitcoin purchases.
Via Stocktwits · May 22, 2025
Analysts raised price targets, citing strong guidance and resilient performance despite macroeconomic challenges.
Via Stocktwits · May 22, 2025
Under the terms of the deal, Sanofi will acquire all outstanding common shares of Vigil for $8 per share in cash at closing.
Via Stocktwits · May 22, 2025
Analysts cited strong execution, product momentum, and optimism for continued growth in 2025.
Via Stocktwits · May 22, 2025
The company closed more than 500 corporate locations in the quarter as part of its store optimization program and opened 10 new ones, resulting in 4,285 stores as of the end of the quarter.
Via Stocktwits · May 22, 2025
Nvidia's quarterly results are due after the market closes on May 28.
Via Stocktwits · May 22, 2025
Users will hear “AI-powered shopping experts” discussing key product features, customer reviews, and related information.
Via Stocktwits · May 22, 2025
CoreWeave went public on March 28 with an initial public offering (IPO) price of $40 per share.
Via Stocktwits · May 22, 2025
About 8.4 million shares are being offered by the company, with the remaining 3.30 million shares by selling shareholders.
Via Stocktwits · May 22, 2025
The company has struggled to regain consumer interest as challenger lifestyle brands gain ground, with sales declining in each of the past three years.
Via Stocktwits · May 22, 2025
The company's report allays investor fears of an all-out slump in retail sales due to President Donald Trump's aggressive and shifting trade policy.
Via Stocktwits · May 22, 2025
Product revenue, accounting for about 96% of the total, climbed 26% to $996.8 million, exceeding the $955 million-960 million guidance.
Via Stocktwits · May 21, 2025
Nike halted direct sales on Amazon in 2019 to focus on its own online and retail channels.
Via Stocktwits · May 21, 2025
With the deal, AT&T hopes to roughly double the availability of its fiber by the end of 2030.
Via Stocktwits · May 21, 2025
The move reportedly helped the company pocket dollars from the government under Medicare Advantage plans while reducing its expenses.
Via Stocktwits · May 21, 2025
Moderna will resubmit the application later this year after data from its ongoing late-stage trial of its seasonal flu vaccine is available.
Via Stocktwits · May 21, 2025
The separation is expected to be accretive to Medtronic’s earnings and operating margin, the company said.
Via Stocktwits · May 21, 2025
Jensen Huang called upon the Trump administration to lower the export curbs before American companies lose market share.
Via Stocktwits · May 21, 2025
The president said his administration has officially selected an architecture for the state-of-the-art system and hopes to deploy next-generation technologies across the land, sea and space.
Via Stocktwits · May 21, 2025
The companies plan to unveil a series of products over time, with the first line of intelligent eyewear likely launching after 2025.
Via Stocktwits · May 21, 2025
The company intends to use the net proceeds to pay off outstanding debt and fund future acquisitions.
Via Stocktwits · May 21, 2025
The results exceeded the Finchat-compiled consensus estimates of $0.77 and $2.28 billion, as well as the company’s own guidance from mid-February.
Via Stocktwits · May 21, 2025
RBC Capital noted that ResMed now has “a number of competitive threats on the horizon."
Via Stocktwits · May 20, 2025